Lee Chih-Kuo, Chen Ying-Hsien, Lin Mao-Shin, Yeh Chih-Fan, Hung Chi-Sheng, Kao Hsien-Li, Huang Ching-Chang
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Acta Cardiol Sin. 2017 Jan;33(1):20-27. doi: 10.6515/acs20160131a.
In percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), most experts regard the antegrade approach as the default initial strategy, reserving the retrograde approach for reattempts following antegrade failure. In this study, we aimed to compare the efficacy and safety between the antegrade and retrograde approaches in CTO PCI.
Between 2012 and 2013, patients that underwent 321 consecutive attempts by high-volume operators (> 75 total CTO PCI cases during the period) in a tertiary university-affiliated hospital were enrolled. The antegrade approach was used in 152 patients, and retrograde in 169 patients. The duration of occlusion was significantly longer and the J-CTO score higher in the retrograde group. Technical success was achieved in 148 patients of the antegrade group (97.4%), and 163 patients in the retrograde group (96.4%) (p = 0.75). A major procedural complication occurred in 3 patients of the antegrade group (2.0%) and in 6 patients of the retrograde group (3.6%) (p = 0.51). In-hospital major adverse cardiac events (MACE) rates (antegrade 0.7%, n = 152; retrograde 0.6%, n = 169) were comparable. The procedure and fluoroscopy times were significantly longer, with more radiation exposure and contrast medium consumption, in the retrograde group. In the retrograde group, similar success, procedural complication and in-hospital MACE rates were achieved in the 3 collateral subgroups.
In selected cases and with highly experienced operators, retrograde approach in CTO PCI is as effective and safe as antegrade approach at the expense of longer procedure time, more radiation exposure and contrast medium consumption. For retrograde approach, either septal, epicardial or AV groove collaterals can be used with similarly success, complication and in-hospital MACE rates.
在慢性完全闭塞病变(CTO)的经皮冠状动脉介入治疗(PCI)中,大多数专家将正向入路视为默认的初始策略,而将逆向入路留作正向失败后的再次尝试。在本研究中,我们旨在比较CTO PCI中正向和逆向入路的疗效和安全性。
2012年至2013年期间,在一所大学附属三级医院中,由高年资术者(在此期间累计完成>75例CTO PCI病例)连续进行321次尝试的患者被纳入研究。152例患者采用正向入路,169例患者采用逆向入路。逆向入路组的闭塞时间明显更长,J-CTO评分更高。正向入路组148例患者(97.4%)技术成功,逆向入路组163例患者(96.4%)技术成功(p = 0.75)。正向入路组3例患者(2.0%)发生主要手术并发症,逆向入路组6例患者(3.6%)发生主要手术并发症(p = 0.51)。住院期间主要不良心脏事件(MACE)发生率(正向0.7%,n = 152;逆向0.6%,n = 169)相当。逆向入路组的手术时间和透视时间明显更长,辐射暴露和造影剂用量更多。在逆向入路组中,3个侧支亚组的成功率、手术并发症和住院期间MACE发生率相似。
在特定病例中,对于经验丰富的术者,CTO PCI中的逆向入路与正向入路一样有效和安全,但代价是手术时间更长、辐射暴露和造影剂用量更多。对于逆向入路,可使用间隔支、心外膜或房室沟侧支,成功率、并发症和住院期间MACE发生率相似。